ZeroStack Corp. (NASDAQ: ZSTK) Stock Competitors & Peer Comparison
See ZSTK's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ZSTK and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZSTK | $5.89 | +18.75% | 6.2M | -0.12 | -$50.57 | N/A |
| MCK | $838.75 | -1.75% | 98.2B | 20.55 | $40.82 | +0.39% |
| COR | $314.69 | -0.76% | 61.2B | 18.35 | $17.15 | +0.76% |
| CAH | $228.46 | -2.72% | 53.5B | 21.90 | $10.43 | +0.89% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $88.46 | -0.93% | 10.1B | 16.66 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| PBH | $50.52 | -2.24% | 2.4B | 11.43 | $4.42 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| ACH | $1.31 | -0.76% | 99.9M | 1.92 | $0.68 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
ZSTK vs MCK Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, MCK has a market cap of 98.2B. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while MCK trades at $838.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas MCK's P/E ratio is 20.55. In terms of profitability, ZSTK's ROE is -3.82%, compared to MCK's ROE of -1.94%. Regarding short-term risk, ZSTK is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
ZSTK vs COR Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, COR has a market cap of 61.2B. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while COR trades at $314.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas COR's P/E ratio is 18.35. In terms of profitability, ZSTK's ROE is -3.82%, compared to COR's ROE of +1.06%. Regarding short-term risk, ZSTK is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
ZSTK vs CAH Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, CAH has a market cap of 53.5B. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while CAH trades at $228.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas CAH's P/E ratio is 21.90. In terms of profitability, ZSTK's ROE is -3.82%, compared to CAH's ROE of -0.60%. Regarding short-term risk, ZSTK is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
ZSTK vs ABC Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas ABC's P/E ratio is 21.92. In terms of profitability, ZSTK's ROE is -3.82%, compared to ABC's ROE of +1.06%. Regarding short-term risk, ZSTK is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
ZSTK vs HSIC Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, HSIC has a market cap of 10.1B. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while HSIC trades at $88.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas HSIC's P/E ratio is 16.66. In terms of profitability, ZSTK's ROE is -3.82%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, ZSTK is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
ZSTK vs PDCO Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas PDCO's P/E ratio is 20.48. In terms of profitability, ZSTK's ROE is -3.82%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, ZSTK is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check PDCO's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
ZSTK vs PBH Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while PBH trades at $50.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas PBH's P/E ratio is 11.43. In terms of profitability, ZSTK's ROE is -3.82%, compared to PBH's ROE of +0.09%. Regarding short-term risk, ZSTK is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check PBH's competition here
Owens & Minor, Inc. (NYSE: OMI)
ZSTK vs OMI Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas OMI's P/E ratio is -0.47. In terms of profitability, ZSTK's ROE is -3.82%, compared to OMI's ROE of +0.63%. Regarding short-term risk, ZSTK is more volatile compared to OMI. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check OMI's competition here
Accendra Health, Inc. (NYSE: ACH)
ZSTK vs ACH Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, ACH has a market cap of 99.9M. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while ACH trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas ACH's P/E ratio is 1.92. In terms of profitability, ZSTK's ROE is -3.82%, compared to ACH's ROE of +0.63%. Regarding short-term risk, ZSTK is more volatile compared to ACH. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
ZSTK vs HX Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas HX's P/E ratio is -1.84. In terms of profitability, ZSTK's ROE is -3.82%, compared to HX's ROE of -1.07%. Regarding short-term risk, ZSTK is more volatile compared to HX. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check HX's competition here
111, Inc. (NASDAQ: YI)
ZSTK vs YI Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, YI has a market cap of 29.8M. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while YI trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas YI's P/E ratio is -2.44. In terms of profitability, ZSTK's ROE is -3.82%, compared to YI's ROE of +0.14%. Regarding short-term risk, ZSTK is more volatile compared to YI. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
ZSTK vs WGRX Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas WGRX's P/E ratio is -0.33. In terms of profitability, ZSTK's ROE is -3.82%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, ZSTK is more volatile compared to WGRX. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check WGRX's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
ZSTK vs MEDS Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, MEDS has a market cap of 3.8M. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while MEDS trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas MEDS's P/E ratio is N/A. In terms of profitability, ZSTK's ROE is -3.82%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, ZSTK is more volatile compared to MEDS. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
ZSTK vs ZYXI Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, ZSTK's ROE is -3.82%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, ZSTK is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check ZYXI's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
ZSTK vs SNYR Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, SNYR has a market cap of 1.2M. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while SNYR trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas SNYR's P/E ratio is -0.08. In terms of profitability, ZSTK's ROE is -3.82%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, ZSTK is more volatile compared to SNYR. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
ZSTK vs RDGT Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, RDGT has a market cap of 724.3K. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while RDGT trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas RDGT's P/E ratio is -0.01. In terms of profitability, ZSTK's ROE is -3.82%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, ZSTK is more volatile compared to RDGT. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
ZSTK vs CVET Comparison August 2026
ZeroStack Corp. (NASDAQ: ZSTK) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZSTK stands at 6.2M. In comparison, CVET has a market cap of 0. Regarding current trading prices, ZSTK is priced at $5.89 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZSTK currently has a P/E ratio of -0.12, whereas CVET's P/E ratio is -69.97. In terms of profitability, ZSTK's ROE is -3.82%, compared to CVET's ROE of -0.06%. Regarding short-term risk, ZSTK is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for ZSTK.Check CVET's competition here